loader from loading.io

Speaking of SurgOnc

"Speaking of SurgOnc" is a podcast series brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology(SSO). Dr. Frederick L. (Rick) Greene, ASO Deputy Editor, will explore and expand upon ideas and concepts described in articles published in the Annals of Surgical Oncology. Dr. Greene will interview authors and leading experts about topics of current importance in surgical oncology.

info_outline Adjuvant Chemoradiation in Resected Biliary Adenocarcinoma: Evaluation of SWOG S0809 with a Large National Database 10/08/2024
info_outline SSO2024 Abstract: Lower Social Support Predicts Higher Cortisol for Breast Cancer Patients in Disadvantaged Neighborhoods 09/10/2024
info_outline Practice Patterns and Outcomes Among Surgical Oncology Fellowship Graduates Performing Complex Cancer Surgery in the United States Across Different Career Stages 08/13/2024
info_outline Extent of Resection and Long-Term Outcomes for Appendiceal Adenocarcinoma: a SEER Database Analysis of Mucinous and non-Mucinous Histologies 07/16/2024
info_outline Docetaxel‑Based Neoadjuvant Chemotherapy Followed by En Bloc Resection for Esophageal Adenocarcinoma: A 15‑Year Retrospective Analysis from a Regional Upper Gastrointestinal Cancer Network 06/11/2024
info_outline The Landmark Series—Addressing Disparities in Breast Cancer Screening: New Recommendations for Black Women 05/21/2024
info_outline Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6 04/09/2024
info_outline Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer 03/12/2024
info_outline Hospital Designations and Their Impact on Guideline-Concordant Care and Survival in Pancreatic Cancer. Do They Matter? 02/13/2024
info_outline Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multicenter Study 01/09/2024
info_outline CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer 12/12/2023
info_outline Neuroendocrine Tumor Liver Metastases: Long-Term Follow-up Evaluation of More Than 500 Patients 11/14/2023
info_outline Endocrine Therapy for Surgeons: Practical Pearls for Managing Menopausal, Bone Loss and Sexual Adverse Effects 10/10/2023
info_outline Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I–III Breast Cancer 09/12/2023
info_outline Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center 08/08/2023
info_outline Exploring the Potential of Artificial Intelligence in Surgery: Insights from a Conversation with ChatGPT 07/11/2023
info_outline A Model to Predict Treatment Failure in Patients Undergoing Upfront Surgery for Resectable Colorectal Liver Metastases 06/13/2023
info_outline Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients 05/09/2023
info_outline Is Routine Omentectomy a Necessary Component of Cytoreductive Surgery and HIPEC? 04/11/2023
info_outline Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292) 03/14/2023
info_outline Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers 02/14/2023
info_outline Patient-Reported Outcome Measures in Patients with Clinical T4 Breast Cancer Treated with Mastectomy with and without Reconstruction 01/10/2023
info_outline Disparities in Utilization and Outcomes of Minimally Invasive Techniques for Gastric Cancer Surgery in the United States 12/20/2022
info_outline Surgical Approach Does Not Affect Return to Intended Oncologic Therapy Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: A Propensity-Matched Study 11/22/2022
info_outline Downstaging of Pancreatic Adenocarcinoma with Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival 10/11/2022
info_outline The Landmark Series: Appendiceal Primary Peritoneal Surface Malignancy 08/16/2022
info_outline Is Medicaid Expansion Narrowing Gaps in Surgical Disparities for Low-Income Breast Cancer Patients?” 07/13/2022
info_outline Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer 06/14/2022
info_outline COVID-19 Is Affecting the Presentation and Treatment of Melanoma Patients in the Northeastern United States 05/10/2022
info_outline Cost Effectiveness of Watch and Wait Versus Resection in Rectal Cancer Patients with Complete Clinical Response to Neoadjuvant Chemoradiation 04/19/2022
 
share